Cargando…
No Resistance to Penicillin, Cefuroxime, Cefotaxime, or Vancomycin in Pneumococcal Pneumonia
Objectives: Group B Streptococcus is a primary source of pneumonia, which is a leading cause of death worldwide. During the last few decades, there has been news of growing antibiotic resistance in group B streptococci to penicillin and different antibiotic agents. This clinical study retrospectivel...
Autores principales: | Yayan, Josef, Ghebremedhin, Beniam, Rasche, Kurt |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4661297/ https://www.ncbi.nlm.nih.gov/pubmed/26664260 http://dx.doi.org/10.7150/ijms.13203 |
Ejemplares similares
-
No Outbreak of Vancomycin and Linezolid Resistance in Staphylococcal Pneumonia over a 10-Year Period
por: Yayan, Josef, et al.
Publicado: (2015) -
No Carbapenem Resistance in Pneumonia Caused by Klebsiella Species
por: Yayan, Josef, et al.
Publicado: (2015) -
No Development of Imipenem Resistance in Pneumonia Caused by Escherichia coli
por: Yayan, Josef, et al.
Publicado: (2015) -
No development of ciprofloxacin resistance in the Haemophilus species associated with pneumonia over a 10-year study
por: Yayan, Josef, et al.
Publicado: (2015) -
Cefepime shows good efficacy and no antibiotic resistance in pneumonia caused by Serratia marcescens and Proteus mirabilis – an observational study
por: Yayan, Josef, et al.
Publicado: (2016)